Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information
| Directive 2001/83 |
| The EU Clinical Trials Regulation |
| EudraLex - Volume 4 - Good Manufacturing Practice (GMP) guidelines |
| EMA Human Medicines | EU Information for Human Medicines |
| Eudralex | EU Legislation for Medicinal Products |
| Eudralex Pharma Section | EU Pharmaceuticals Information |
| Eudralex Volume 1 - Legislation Human | EU Legislation for Human Medicinal Products |
| Eudralex Volume 3 - Guidelines Human | EU Scientific Guidelines for Human Medicinal Products |
| Eudralex Volume 4 - GMP Human and Veterinary | EU GMP Guidelines for Human and Veterinary Medicinal Products |
| Good Distribution Practice | Guideline on Good Distribution Practice |
| Mutual Recognition Agreements (MRAs) | Information on Mutual Recognition Agreements between EU and Non-EU Countries |
| UK Medicines Act 1968 | UK Legislation on Medicines |
| Licensing of Medicines | Information on Licensing of Medicines in the UK |
| UK GMP | Information on UK GMP |
| UK Guidance Notes | UK Guidance Notes for Medicines |
| GMP Q&A | MHRA Frequently Asked Questions on GMP |
| UK S2012/1916 | The Human Medicines Regulations 2012 |
| CFRs | US Legislation on Food, Drugs and Cosmetics |
| FDA Investigations Operation Manual | Guidance on FDA Inspections - General |
| FDA Inspection Guides | Guidance on FDA Inspections - Specific Topics |
| FDA CBER Guidance/Guidelines/Points to Consider | FDA Guidances and Regulatory Information for Biologics |
| FDA CDER Guidances | FDA Guidances and Regulatory Information for Drug Products |
| FDA Guidance for Industry - Sterile Drug Products Produced by Aseptic Processing Current GMP | US Guidance on Requirements for Aseptically Manufactured Drug and Biological Products |
Click here to view the process which covers planning, types of inspection, notification, conduct, definition of deficiencies, post-inspection letter, referal to Inspection Action Group, company responses and inspection report.